Skip to main content
. Author manuscript; available in PMC: 2010 Jun 18.
Published in final edited form as: Inflamm Bowel Dis. 2009 May;15(5):684–696. doi: 10.1002/ibd.20824

FIGURE 7.

FIGURE 7

Evaluation of colitis in B6 and B6.mdr1a−/− mice following treatment with piroxicam. Body weight in B6 and B6.mdr1a−/− undergoing treatment with Piroxicam (A). Colonic histology of B6 (B), and B6.mdr1a−/− (C) animals at sacrifice. Colonic length (D) and histological scores of treated animals (E). Images captured at 100X magnification. Bar=100µm. * Indicates statistical significance of P<0.05 as determined by Mann Whitney analysis when comparing piroxicam treated P-gp deficient and control strain animals.